iifl-logo

Nectar Lifescience Ltd Board Meeting

22.11
(-0.41%)
Apr 30, 2025|12:09:32 PM

Nectar Lifesci. CORPORATE ACTIONS

30/04/2024calendar-icon
30/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting31 Jan 202524 Jan 2025
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Financial Results for the quarter and nine months ended on December 31 2024 and Other Business Matters. Outcome of Board Meeting (As per BSE Announcement Dated on 31/01/2025)
Board Meeting14 Nov 20244 Nov 2024
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Financial Results for the quarter and half year ended on September 30 2024 and other business matters. Outcome of Board Meeting dated November 14, 2024 (As Per Bse Announcement Dated on 14.11.2024)
Board Meeting14 Aug 20243 Aug 2024
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the company will be held on Wednesday August 14 2024 to consider and approve inter alia amongst other items: 1. the Unaudited Financial Results for the quarter ended on June 30 2024 and matters related thereto; and 2. to convene the Annual General Meeting on September 21 2024 and matters related thereto. Please find attached herewith the financial results for the quarter ended on June 30, 2024 (As Per BSE Announcement Dated on 14.08.2024)
Board Meeting15 May 20248 May 2024
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve the Audited Financial Results for the Financial Year 2023-24 Financial Statements of the Company for the Financial Year 2023-24 and matters related thereto. Audited Financial Results and outcome of Board Meeting Outcome of Board Meeting - Reappointment of Cost Auditors and Secretarial Auditors (As Per BSE Announcement dated on 15.05.2024)

Nectar Lifesci.: Related News

European Regulators Raise Concerns Over Nectar Lifesciences’ API Facility
11 Mar 2025|01:42 PM

The facility was inspected primarily to assess its compliance with European Good Manufacturing Practices (EuGMP).

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.